The Complete Guide to Peptide Therapy in 2026

What Is Peptide Therapy?

Peptide therapy uses specific amino acid sequences to influence cellular signaling pathways. When a peptide binds to a receptor on a cell’s surface or enters the cell directly, it triggers a cascade of biochemical events—stimulating growth factor release, modulating inflammatory cytokines, enhancing mitochondrial function, or prompting neurotransmitter synthesis. These actions are highly targeted compared to traditional pharmaceuticals because peptides interact with the same pathways the body already uses for self-regulation.

Administration routes vary by peptide. Subcutaneous injection is the most common method for systemic peptides like BPC-157 and growth hormone-releasing peptides. Topical application is standard for cosmetic peptides such as GHK-Cu and Argireline. Intranasal delivery has gained traction for neuroactive peptides like Selank and Semax because the olfactory mucosa provides direct access to the central nervous system, bypassing the blood-brain barrier.

Peptides are synthesized through solid-phase peptide synthesis (SPPS) or recombinant DNA technology. Pharmaceutical-grade peptides undergo rigorous purity testing via high-performance liquid chromatography (HPLC), mass spectrometry, and endotoxin screening. Purity levels above 98% are standard for clinical use. Stability varies significantly: most reconstituted peptides require refrigeration at 2–8°C and have a shelf life of 4–8 weeks once mixed with bacteriostatic water.

Therapeutic Peptides Library

Regenerative & Healing Peptides

Growth Hormone Secretagogues

Cosmetic & Skin Peptides

Sexual Health & Wellness

Neuroactive & Sleep Peptides

Immune & Gut Peptides

Common Protocols

Peptide protocols vary widely by compound class, therapeutic goal, and individual response. Most regenerative peptides follow a loading and maintenance pattern. BPC-157 is typically dosed at 250–500 mcg once or twice daily via subcutaneous injection near the injury site for 4–8 weeks. TB-500 uses a higher loading dose of 2–2.5 mg twice weekly for 4–6 weeks, followed by a maintenance phase of 2 mg every two weeks.

Growth hormone secretagogue protocols center on pulsatile dosing to mimic the body’s natural GH rhythm. CJC-1295/Ipamorelin is typically administered at 100 mcg of each peptide before bed on an empty stomach, five nights per week, cycling 12 weeks on and 4 weeks off. Sermorelin follows a similar pattern at 200–300 mcg nightly. GHRP-2 and GHRP-6 are dosed at 100–300 mcg two to three times daily, ideally 30 minutes before meals and at bedtime. Fasting for at least two hours before injection maximizes the GH pulse because elevated blood sugar and insulin blunt the response.

Cosmetic peptides require consistent topical application over 8–12 weeks. GHK-Cu serums are applied once or twice daily to clean skin. Argireline and SNAP-8 concentrations of 5–10% are applied to expression line areas. Neuroactive peptides like Semax (200–600 mcg intranasal daily) and Selank (250–500 mcg intranasal daily) follow 2–4 week cycles with equal rest periods.

PT-141 is dosed at 1.75 mg subcutaneously as needed, approximately 45 minutes before desired effect, with no more than 8 doses per month. DSIP protocols use 100–200 mcg subcutaneously 30 minutes before bedtime for 10–14 consecutive nights. Thymosin Alpha-1 is dosed at 1.6 mg subcutaneously twice weekly for immune support, often used continuously in clinical settings for chronic infections.

Who Should Consider Peptide Therapy?

Peptide therapy appeals to a broad range of individuals. Athletes and active adults with soft-tissue injuries often turn to BPC-157 and TB-500 to support recovery. Adults over 30 experiencing declining growth hormone output may benefit from GH secretagogue protocols to improve body composition, sleep quality, and skin health. Patients with chronic gut issues explore peptides like BPC-157 and Larazotide for intestinal barrier support.

Those seeking non-surgical anti-aging solutions use cosmetic peptides like GHK-Cu and Argireline for collagen support and wrinkle reduction. Individuals with stress-related cognitive decline may benefit from Semax or Selank. Immunocompromised patients have used Thymosin Alpha-1 under medical supervision for decades. Anyone considering peptide therapy should work with a knowledgeable clinician who can monitor bloodwork and tailor protocols.

Monitoring & Safety

Baseline and follow-up bloodwork is essential. Before starting any peptide protocol, obtain a comprehensive metabolic panel (CMP), complete blood count (CBC), fasting insulin and glucose, hemoglobin A1c, IGF-1, and a lipid panel. For growth hormone secretagogues, IGF-1 levels are the primary marker—check at baseline, 6 weeks, and 12 weeks. Target IGF-1 should remain within the upper quartile of the age-adjusted reference range (typically 200–300 ng/mL for adults under 50).

Monitor fasting glucose and HbA1c every 3 months during GH secretagogue use, as elevated GH can reduce insulin sensitivity. Watch for signs of water retention, joint stiffness, or carpal tunnel-like symptoms, which indicate IGF-1 levels may be too high. For immune peptides like Thymosin Alpha-1, track lymphocyte subsets (CD4/CD8 ratio) and inflammatory markers (CRP, ESR) at baseline and quarterly.

Injection site reactions—redness, mild swelling, or itching—are the most common side effect and typically resolve within minutes. Rotate injection sites regularly. Store reconstituted peptides at 2–8°C and discard after the recommended timeframe (usually 4–6 weeks). Never share vials or use cloudy solutions. Report any unusual symptoms (persistent headaches, vision changes, significant edema) to your healthcare provider immediately.

Frequently Asked Questions

Are peptides legal to use?

In the United States, many peptides are available through compounding pharmacies with a valid prescription. The FDA regulates peptides as drugs when they are intended for therapeutic use. Some peptides, like PT-141 (Vyleesi®), have full FDA approval. Others are prescribed off-label by licensed clinicians. Research-use-only peptides are legal to purchase but not approved for human consumption without medical oversight.

How quickly do peptides work?

Onset varies significantly by peptide. BPC-157 users often report reduced pain within 1–2 weeks. GH secretagogues typically show measurable IGF-1 changes within 4–6 weeks, with body composition changes over 3–6 months. Cosmetic peptides require 8–12 weeks of consistent use to show visible skin improvements. Neuroactive peptides like Semax may show cognitive benefits within days.

Can I stack multiple peptides together?

Yes, peptide stacking is common and often recommended for synergistic effects. CJC-1295 plus Ipamorelin is the classic GH stack. BPC-157 combined with TB-500 is standard for tissue repair. However, stacking should be done methodically—introduce one peptide at a time, assess response for 2–4 weeks, then add the next. This approach helps identify which compounds you respond to and makes it easier to manage side effects.

What is the difference between peptides and steroids?

Peptides are amino acid chains that signal the body to upregulate its own natural processes—such as increasing growth hormone production rather than injecting exogenous GH. Anabolic steroids are synthetic hormones that directly replace or supplement the body’s hormones, often causing suppression of natural production. Peptides generally have a more favorable side-effect profile and work within physiological ranges, while steroids push the body beyond its natural limits.